SEC Form 3 · accession 0001790340-26-000080
Immuneering Corp · IMRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrew Gengos
Officer — Chief Financial Officer
Period of report
Jul 16, 2026
Accepted (ET)
Jul 16, 2026 · 4:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001790340
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | holding | — | — | — | 225,000 | D |
Table II — derivative securities
No Table II lines on this filing.